ASX:VEA
ASX:VEAOil and Gas

How Viva Energy’s Board Renewal and New Chair Will Impact Viva Energy Group (ASX:VEA) Investors

Viva Energy Group announced that long-serving Chair Robert Hill will retire on 1 March 2026, with current Director Dr Sarah Ryan named Chair elect and experienced executive Alistair Bell joining the Board as an Independent Non-Executive Director on the same date. This refresh brings energy industry depth and financial leadership to the Board, potentially influencing how Viva Energy balances operational discipline with long-term growth priorities. Against this backdrop of board renewal, we’ll...
ASX:ORG
ASX:ORGElectric Utilities

How Investors Are Reacting To Origin Energy (ASX:ORG) Extending Eraring Coal Plant’s Operating Life

Origin Energy has delayed the retirement of its 2,880 megawatt Eraring coal-fired power station in New South Wales from August 2027 to April 2029, after authorities identified ongoing system security and reliability risks during Australia’s energy transition. This extension highlights how aging coal capacity remains critical to grid stability while renewable generation, storage projects, and major transmission upgrades are still being developed. We’ll now examine how extending Eraring’s...
ASX:WWG
ASX:WWGLogistics

3 ASX Penny Stocks With Market Caps Under A$600M

The Australian market is experiencing a turbulent period, with losses gathering steam amid global economic uncertainties and delayed U.S. trading activity. Despite these challenges, investors continue to seek opportunities in various corners of the market, including penny stocks. While the term 'penny stock' might seem outdated, it still signifies potential growth opportunities in smaller or newer companies that can offer value when backed by strong financials.
ASX:MSB
ASX:MSBBiotechs

Mesoblast (ASX:MSB) Valuation Check After FDA Backs Rexlemestrocel L’s Pain And Opioid Reduction Data

Mesoblast (ASX:MSB) is back in focus after feedback from the U.S. FDA on its rexlemestrocel L cell therapy, which targets chronic discogenic low back pain and is directly linked to opioid use reduction. See our latest analysis for Mesoblast. Despite the positive FDA feedback, Mesoblast’s recent share price momentum has been soft, with a 7 day share price return of a 7.0% decline and a 30 day share price return of a 12.7% decline, while the 3 year total shareholder return of 177.6% points to a...
ASX:JHX
ASX:JHXBasic Materials

A Look At James Hardie Industries’ (ASX:JHX) Valuation As Plant Closures Aim For Future Cost Savings

James Hardie Industries (ASX:JHX) is back in focus after announcing plans to close its Fontana, California, and Summerville, South Carolina manufacturing plants within 60 days and to consolidate capacity under a broader optimization program. See our latest analysis for James Hardie Industries. The plant closures come after a sharp share price rally, with a 15.54% 30 day share price return and a 13.02% year to date share price return, even as the 1 year total shareholder return shows a 36.53%...
ASX:DJW
ASX:DJWCapital Markets

Djerriwarrh Investments H1 2026 Margin Compression Challenges High Quality Earnings Narrative

Djerriwarrh Investments (ASX:DJW) has put out its H1 2026 numbers, reporting total revenue of A$24.8 million and basic EPS of A$0.079, with trailing twelve month EPS of A$0.146 on revenue of A$51.6 million. Over the last three reported halves, revenue has moved between A$24.8 million and A$26.7 million while basic EPS has ranged from A$0.067 to A$0.081. This gives investors a clear view of how earnings per share have tracked relative to a fairly steady top line. With trailing net profit...
ASX:BGL
ASX:BGLMetals and Mining

3 ASX Stocks That May Be Priced Below Their Intrinsic Value Estimates

As the Australian share market faces a slight dip amid global trade tensions and tariff threats, investors are keenly observing opportunities that may arise from these fluctuations. In such an environment, identifying stocks that might be priced below their intrinsic value becomes crucial for those looking to capitalize on potential market inefficiencies.
ASX:PTN
ASX:PTNMetals and Mining

3 ASX Penny Stocks With Market Caps Under A$500M

The Australian stock market is experiencing a slight dip, with shares expected to open 0.3% lower due to global economic factors such as new tariffs from the U.S. on Europe. Despite these challenges, there are still opportunities for investors looking at smaller or newer companies often referred to as penny stocks. While the term may seem outdated, these stocks can offer significant potential when they are backed by strong financials and solid fundamentals, providing an intriguing area of...
ASX:PPS
ASX:PPSSoftware

Undervalued Global Small Caps With Insider Buying In January 2026

As the global markets navigate a mixed landscape, small-cap and value stocks have emerged as leaders, with indices like the Russell 2000 and S&P MidCap 400 reaching all-time highs. This environment highlights the potential for discerning investors to explore opportunities in smaller companies that may be poised for growth amidst broader economic shifts. In this context, identifying small-cap stocks with strong fundamentals and positive insider activity can be a strategic move for those...